Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Biotheus Announces Strategic Research Collaboration and Worldwide License Agreement with BioNTech 2023-07-20 09:01
Gannex Announces the Completion of Patient Enrollment for Phase II Clinical Trial of ASC42, an FXR Agonist, for Primary Biliary Cholangitis 2023-07-20 08:10
Telix Reports Continued Double-Digit Revenue Growth and Positive Operating Cash Flow 2023-07-19 16:14
The International Conference on Pharmaceutical Innovation and Development 2023 Kicked off in Yantai 2023-07-19 16:09
Yikaida CAR-T Cell Therapy Approved as a Second-line Therapy for New Indication 2023-07-19 10:42
Daewoong Pharmaceutical has obtained approval for SGLT2i + metformin combination drug Envlomet 2023-07-19 08:52
First Patient Dosed in STARSTRUCK Study of TLX250 Targeted Radiation Therapy in Combination with Merck Investigational DNA-PK Inhibitor, Peposertib 2023-07-19 05:00
Mabwell Announces the NMPA Approval of Novel Trop-2 ADC (9MW2921) for IND 2023-07-19 00:00
Samsung Biologics releases 2023 ESG Report, reaffirming its commitment to net-zero progress and corporate social responsibility 2023-07-18 19:00
Viva Biotech's Portfolio Company DTx Pharma Reached the Acquisition Agreement with Novartis 2023-07-18 15:00
Join Taipei City's Thriving Health Industry: Registration for "Win A Greater Health" Pitch Contest Starts Now! 2023-07-18 11:35
SK Biopharmaceuticals Makes Big Bets to be 'Big Biotech' 2023-07-18 09:00
Antengene Announces First Patient Dosed in the Nivolumab Combination Portion of the Clinical Study Evaluating the ERK1/2 Inhibitor ATG-017 in Patients with Advanced Solid Tumors in the United States 2023-07-18 08:30
Qilian International Holding Group Ltd Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency 2023-07-17 22:30
BIORCHESTRA Wins Grand Prize in 2023 Merck Advance Biotech Grant Program 2023-07-17 21:28
ALZHEIMER'S ASSOCIATION STATEMENT ON DONANEMAB PHASE 3 DATA REPORTED AT AAIC 2023 2023-07-17 21:15
GeneQuantum and InxMed have reached a technology licensing collaboration, providing strong support for innovative ADC drug research and development 2023-07-17 17:00
Antengene Announces XPOVIO® Regulatory Approval in Hong Kong for the Treatment of Relapsed and/or Refractory Multiple Myeloma 2023-07-17 08:30
Red Marrow Peptide-A Major Breakthrough in Human Health Engineering 2023-07-14 12:51
Menarini Silicon Biosystems announces the launch of its new CELLSEARCH® CTC test with the DLL3 biomarker for small cell lung cancer 2023-07-13 20:00
1 53 54 55 56 57 375